-The Business Standard A CACP study shows how the Fisc, rising farm wages and international forces are stoking inflation It's good to see that independent thought is still present in the government. When one part of the government comes out with a serious and objective piece on how the government itself has been responsible for creating food inflation, hopefully the government is more likely to take note. The Commission for Agricultural Costs and...

-The Hindu     Protesters see attempt by EU to undermine Indian judiciary in the EU-FTA pact People living with HIV, cancer patient groups and public health activists came out on the streets on Wednesday demanding that India reject the European Union's demands in the European Union-India Free Trade Agreement (EU-India FTA) negotiations. The protests coincide with Prime Minister Manmohan Singh's visit to Germany to meet Chancellor Angela Merkel with the FTA on top of...

-The Hindu     A computerised database of ration card holders and purchases is a safeguard against diversion of PDS supplies but the process can be disruptive for beneficiaries The government has initiated an interesting pilot for the Public Distribution System (PDS) in East Godavari, Andhra Pradesh. When cardholders go to buy their PDS rations, their ration card number and UID (Unique Identification) number are punched into an "e-Point of Sale" (ePOS) machine. If...

-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon...

-The Hindustan Times Cancer drugs will cost almost 25% less if the regulator implements a new formula that calls for a price cap. The price regulator National Pharmaceutical Pricing Authority (NPPA) is considering a pricing mechanism similar to the one for insulin products - which has brought down prices by up to 40% - for 33 cancer drugs, most of them generics. Basically, the lowest price from the list of drugs in a...